• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.39 número3

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.39 número3"

Copied!
2
0
0

Texto

(1)

rev bras hematol hemoter. 2017;39(3):189–190

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Scientific

Comment

Adjusting

thresholds

of

serum

ferritin

for

iron

deficiency:

a

moving

target

Flávio

Augusto

Naoum

AcademiadeCiênciaeTecnologia(AC&T),SãoJosédoRioPreto,SP,Brazil

Irondeficiencyanemia(IDA)iswidelyprevalentinpatientsof allages.1Inchildrenandyoungadults,thediagnosisofIDAis

ratherstraightforward.Inelderlypatients,however,the pres-enceofcomorbiditiesusuallyhamperspromptdiagnosisby conventionalironprofiletests.2

Whenlimitedtoconventionalironmeasuresduring eval-uationsofsuspectedIDAinanelderlypatientwithanormal ferritinlevel,transferringsaturationbecomesmorereliablefor diagnosticpurposes.Comorbidity-related inflammationcan compromisetheaccuracyofirontests,notablyserumferritin, whichisanacutephasereactantitself.2,3Therefore,inorderto

ascertainthediagnosisofIDAinelderlypatients,itisadvisable totakeotherironparametersintoaccount,suchastransferrin saturation.

Moreover,itisimportanttoquestionwhata‘normal’serum ferritinlevelreallyisforthispatient,sinceadoptionof com-monlyusedcut-off values(rangingfrom 15to30ng/mL) to confirmIDAwouldresultinalargenumberofundiagnosed patientsamongtheelderly.4Adistinctionbetweenabsolute

and functional irondeficiency inthis context iscrucial.In absoluteirondeficiency,serumferritinlevelstendtomirror lowironreservesunlessfalselyelevateddueto inflammation-relatedconditions.Ontheotherhand,achronicinflammatory process is frequently associated with functional iron defi-ciency, a condition in which, in spite of satisfactory iron reserveswithnormalorevenincreasedserum ferritin,the availabilityofironforthebonemarrowislimitedsubstantially duetoincreasedhepcidintranscription.5

DOIoforiginalarticle:http://dx.doi.org/10.1016/j.bjhh.2017.02.002.

SeepaperbyBabaeietal.onpages223–8.

Correspondingauthorat:AcademiadeCiênciaeTecnologia(AC&T),R.BonfáNatale,1860,SantosDumont,15020-130SãoJosédoRio

Preto,SPBrazil.

E-mailaddress:drflavio@institutonaoum.com.br

ThestudybyBabaeietal.6inthisissueoftheBrazilian

Jour-nalofHematologyandHemotherapyaimedatobtainingan appropriatecut-offlevelforserumferritinthatwouldbetter discriminatebetweenelderlypatientswithandwithoutIDA. Theauthorshadtheopportunity–andtheprivilege–torecruit averyhomogeneouscohortofelderlypatientsintermsof eth-nicity,demographicsandlifestyle.Athresholdof100ng/mL forserumferritinyieldedasensitivityof60%andspecificityof 59%forIDAdetection,employingalowtransferrinsaturation levelasthereferencetesttoconfirmdiagnosis.

Inthiscontext,asensitivityandspecificityofaround60%to confirmIDAbyadistinctserumferritinthresholdseems rea-sonable,asshownbyBabaeietal.andothers.7Forinstance,

the cut-off value forhemoglobinA1C todiagnose diabetes mellitus hasalsobeen amatter ofdebate, sincethe tradi-tionally adopted cut-off point of 6.5% onlyaccounts for a sensitivityof43%,whereasatacut-offpointof6.2%,the sen-sitivitywouldincreaseto60%,inspiteofsimilarspecificities forbothpoints.8

Itisnoteworthy,however,thatfindingadistinctive thresh-oldforserumferritininspecificpopulationsisachallenging task thatrelies essentiallyon the choice ofthe parameter adopted as the gold standard for IDA diagnosis. Although transferrin saturation levels have been adoptedfor this in somestudies,their usehaslimitations.Forexample,when stainable ironinthebonemarrowwas adoptedasthe ref-erencestandard,transferrinsaturationlevelsbelow20%had asensitivityof60% andspecificity of48% indetectingIDA

http://dx.doi.org/10.1016/j.bjhh.2017.03.002

(2)

190

revbrashematolhemoter.2017;39(3):189–190

inanemic patientswith meanage of68;hence,therewas aconsiderableoverlapbetweentheiron-deficientand iron-sufficientgroups.9 Alternatively, instead ofselectingagold

standardmethodtoinfertheapplicabilityofagiventestto confirmIDA,aninterestingandlessinvasiveapproachwould bethecombinationoftheconventionalironmeasureswith newerreliableparameterssuchastransferrinreceptor, retic-ulocytehemoglobinandmeasurementsoftheproportionof hypochromicredbloodcellswhichallowearlyrecognitionof IDA.10

Any effort to improve IDA detection in patients with comorbidities is highly welcome, since misdiagnosing or underdiagnosing this type ofanemia byconventional iron testswithfixedreferencerangescanleadtoinsufficientor equivocaltreatment.Itisimportanttokeepinmindthatiron testsarehighlyvolatileinelderlypatientswithcomorbidities, andpersonalizationofreferencerangesinthisspecific pop-ulationcanimproveaccuracyofIDAconfirmation,especially whenthisconditionisclinicallysuspected.

Conflicts

of

interest

Theauthordeclaresnoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1. WorldHealthOrganization.Worldwideprevalenceofanaemia 1993–2005.WHOGlobalDatabaseonAnaemia.Available from:http://apps.who.int/iris/bitstream/10665/43894/1/

9789241596657eng.pdf[cited06.03.17].

2.WorldHealthOrganization.JointWorldHealth

Organization/CentersforDiseaseControlandPrevention

TechnicalConsultationontheAssessmentofIronStatusat

thePopulationLevel.Assessingtheironstatusofpopulations

–secondedition,includingliteraturereviews.2nded.Geneva:

Switzerland;2004.

3.NaoumFA.Irondeficiencyincancerpatients.RevBras

HematolHemoter.2016;38(4):325–30.

4.HoJC,StevicI,ChanA,LauKK,ChanHH.Serumferritinisnot

sensitiveorspecificforthediagnosisofirondeficiencyin

patientswithnormocyticanemia.Blood.2015;126(23):955.

5.GoodnoughLT,NemethE,GanzT.Detection,evaluation,and

managementofiron-restrictederythropoiesis.Blood.

2010;116(23):4754–61.

6.BabaeiM,ShafieeS,HeidariB,HosseiniSR,SadeghiMV.

Abilityofserumferritinfordiagnosisofirondeficiency

anemiainanelderlycohort.RevBrasHematolHemoter.

2017;39(3):223–8.

7.OngKH,TanHL,LaiHC,KuperanP.Accuracyofvariousiron

parametersinthepredictionofirondeficiencyinanacute

carehospital.AnnAcadMedSingapore.2005;34(7):437–40.

8.GuoF,MoelleringDR,GarveyWT.UseofHbA1cfordiagnoses

ofdiabetesandprediabetes:comparisonwithdiagnoses

basedonfastingand2-Hrglucosevaluesandeffectsof

gender,race,andage.MetabSyndrRelatDisord.

2014;12(5):258–68.

9.KisAM,CarnesM.Detectingirondeficiencyinanemic

patientswithconcomitantmedicalproblems.JGenIntern

Med.1998;13(7):455–61.

10.NaoumFA.Doenc¸asquealteramosexameshematológicos.

Referências

Documentos relacionados

(iii) By using quantitative fluorescent beads labeled with a known number of phycoerythrin (PE) molecules, the curve of fluorescence intensity can be extrapolated to evaluate the

Figure 3 – No significant difference in event-free survival was found for acute lymphoblastic leukemia children with no antibodies compared to those with immunoglobulin (Ig)G, IgE

The molecular response profile of patients with samples in all time intervals ( n = 82) showed in the first interval (three to five months) that 78.1% (64/82) had 1 log reduction in

An Excel spreadsheet was sent to all participating insti- tutions, who were asked to provide the following data: patient’s initials; gender; histologic subtype; date of birth; date

Table 2 – Prevalence of chronic medical conditions in patients with and without iron deficiency anemia in elderly subjects aged 60 years and more. Chronic medical conditions

Know- ing the human leukocyte antigens allele group and haplotype frequencies as well as the linkage disequilibrium between alleles of different human leukocyte antigens loci

The objective of this study was to compare miRNA expression profiles of patients with Binet A chronic lymphocytic leukemia with those of sub- jects with high-count monoclonal

Table 1 – Original and Portuguese version of Blood/Injection Fear Scale and the results of content validity ratio (CVR). estimated for